Skip to main content
Figure 1 | BMC Medical Genetics

Figure 1

From: The CARD8 p.C10X mutation associates with a low anti-glycans antibody response in patients with Crohn’s disease

Figure 1

Measurement of anti-mannan antibody levels in human sera according to p. C10X genotype. Anti-mannan antibody (ASCA) levels were determined in sera from CD probands (A) and healthy first-degree relatives (B) by ELISA. Antibody titers (expressed in AU according to the reactivity of the manufacturer’s calibrator) in samples from subjects who were wild-type (C/C), heterozygous (C/X), or homozygous (X/X) for the p.C10X mutation. Positive or negative ASCA status was determined according to the cutoff value of 50 AU determined according to the manufacturer's instruction.

Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us